Gabapentin Enacarbil Market Growth, Share, Trends, Key Players, and Forecast by 2034

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034

Coverage: Gabapentin Enacarbil Market covers analysis By Type (Capsule, Tablet); Application (Post-Herpetic Neuralgia (PHN), Restless Legs Syndrome (RLS), Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Report Date : Feb 2026
Report Code : TIPRE00018109

Category : Life Sciences
Status : Upcoming

Available Report Formats :
No. of Pages : 150

Also Available in :

Korean German Japanese French Chinese Italian Spanish

Buy Now

Page Updated: Jan 2025

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Gabapentin Enacarbil Market is anticipated to expand at a CAGR of 5.2% from 2026 to 2034. Market conditions continue to evolve, leading to new opportunities for stakeholders. The overall landscape reflects stable progress and long-term growth potential.

The Gabapentin Enacarbil Market Report is segmented by type into Capsule and Tablet. The application segment includes Post-Herpetic Neuralgia and Restless Legs Syndrome. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Gabapentin Enacarbil Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Gabapentin Enacarbil Market Segmentation Type

Capsule
Tablet

Application

Post-Herpetic Neuralgia
Restless Legs Syndrome

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Gabapentin Enacarbil Market: Strategic Insights

Get Top Key Market Trends of this report.
This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Gabapentin Enacarbil Market Growth Drivers

Prevalence of Neurological Disorders: The increasing prevalence of neurological conditions like epilepsy, neuropathic pain, and restless leg syndrome is driving the demand for gabapentin enacarbil as an effective treatment.
Aging Population: The rising global aging population is contributing to a higher incidence of neurological disorders, further boosting the demand for gabapentin enacarbil.
Growing Awareness and Research: Increasing awareness of gabapentin enacarbil's efficacy and ongoing research to explore new applications and formulations are expected to drive market growth.

Side Effects and Alternative Treatments: Despite its potential, the drugReport Scope

Gabapentin Enacarbil Market Regional Insights

The regional trends and factors influencing the Gabapentin Enacarbil Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Gabapentin Enacarbil Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Gabapentin Enacarbil Market Report Scope

By Application

Post-Herpetic Neuralgia
Restless Legs Syndrome

Europe

UK
Germany
France
Russia
Italy
Rest of Europe

Asia-Pacific

China
India
Japan
Australia
Rest of Asia-Pacific

South and Central America

Brazil
Argentina
Rest of South and Central America

Middle East and Africa

South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa

Report Attribute	Details
Market size in 2025	US$ XX Million
Market Size by 2034	US$ XX Million
Global CAGR (2026 - 2034)	5.2%
Historical Data	2021-2024
Forecast period	2026-2034
Segments Covered	By Type Capsule Tablet
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	GlaxoSmithKline plc Sun Pharmaceutical Industries Ltd. Novartis AG Pfizer Inc. Glenmark Pharmaceuticals Limited Astellas Pharma Inc. AstraZeneca plc Aurobindo Pharma. Takeda Pharmaceutical Company Limited

Gabapentin Enacarbil Market Players Density: Understanding Its Impact on Business Dynamics

The Gabapentin Enacarbil Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Get the Gabapentin Enacarbil Market top key players overview

Frequently Asked Questions

What are the deliverable formats of the Gabapentin Enacarbil Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Which are the leading players operating in the Gabapentin Enacarbil Market?

The leading players of the market are: GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Novartis AG Pfizer Inc., Glenmark Pharmaceuticals Limited, Astellas Pharma Inc., AstraZeneca plc, Aurobindo Pharma., Takeda Pharmaceutical Company Limited, Intas Pharmaceuticals Ltd.

What are the future trends of the Gabapentin Enacarbil Market?

There is significant promise in the Gabapentin Enacarbil market, as the trends emerging are multifarious. Innovative formulations and delivery systems that improve patient compliance and, thus, treatment efficacy are crucial developments in this field. More studies on gabapentin enacarbil are being conducted, opening doors to new applications of this medication for neurological disorders such as migraine and fibromyalgia. This will further increase the emphasis on personalized medicine and pharmacogenomics, which may lead to more targeted and effective use of gabapentin enacarbil, optimizing treatment outcomes for individual patients.

What is the expected CAGR of the Gabapentin Enacarbil Market?

Gabapentin Enacarbil Market is expected to grow at a CAGR of 5.2% between 2026-2034

What are the driving factors impacting the Gabapentin Enacarbil Market?

The primary drivers for the Gabapentin Enacarbil market are the increasing prevalence of neurological disorders such as epilepsy, neuropathic pain, and restless leg syndrome. The aging population, combined with growing awareness of these conditions, is driving demand for effective treatments. Further research and development activities focused on new applications and formulations of gabapentin enacarbil will also contribute to the growth of the market.

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Gabapentin Enacarbil Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

RAN KEDEM Partner, Reali Technologies LTDs

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

JEAN-HERVE JENN Chairman, Future Analytica

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

Reason to Buy